Gronthos S, Stewart K, Graves S E, Hay S, Simmons P J
Matthew Roberts Laboratory, Leukaemia Research Unit, Hanson Centre for Cancer Research, I.M.V.S., Adelaide, Australia.
J Bone Miner Res. 1997 Aug;12(8):1189-97. doi: 10.1359/jbmr.1997.12.8.1189.
The integrin family of cell adhesion molecules are a series of cell surface glycoproteins that recognize a range of cell surface and extracellular matrix (ECM)-associated ligands. To date, the precise role of individual integrin molecules in bone cell-ECM interactions remains unclear. Cell binding assays were performed to examine the ability of normal human bone cells (NHBCs) to adhere to different ECM proteins in vitro. NHBCs displayed preferential adhesion to fibronectin over collagen types I, IV, and vitronectin and showed low affinity binding to laminin and collagen type V. No binding was observed to collagen type III. The integrin heterodimers alpha 1 beta 1, alpha 2 beta 1, alpha 3 beta 1, alpha 5 beta 1, alpha v beta 3, and alpha v beta 5 were found to be constitutively expressed on the cell surface of NHBCs by flow cytometric analysis. The integrins alpha 4 beta 1 and alpha 6 beta 1 were not expressed by NHBCs. Subsequent binding studies showed that NHBC adhesion to collagen and laminin was mediated by multiple integrins where cell attachment was almost completely inhibited in the presence of a combination of function-blocking monoclonal antibodies (Mabs) to alpha 1 beta 1, alpha 2 beta 1, alpha 3 beta 1, and beta 1. In contrast, the adhesion of NHBCs to fibronectin was only partially inhibited (50%) in the presence of blocking Mabs to alpha 3 beta 1, alpha 5 beta 1, and beta 1. The attachment of NHBCs to collagen, laminin, fibronectin, and vitronectin was also found to be unaffected in the presence of a function-blocking Mab to alpha v beta 3. The results of this study indicate that beta 1 integrins appear to be the predominant adhesion receptor subfamily utilized by human osteoblast-like cells to adhere to collagen and laminin and in part to fibronectin.
细胞黏附分子整合素家族是一系列细胞表面糖蛋白,可识别多种细胞表面及细胞外基质(ECM)相关配体。迄今为止,单个整合素分子在骨细胞与ECM相互作用中的精确作用仍不清楚。进行细胞结合试验以检测正常人骨细胞(NHBCs)在体外黏附于不同ECM蛋白的能力。与I型、IV型胶原蛋白及玻连蛋白相比,NHBCs对纤连蛋白表现出优先黏附性,对层粘连蛋白和V型胶原蛋白表现出低亲和力结合。未观察到与III型胶原蛋白的结合。通过流式细胞术分析发现,整合素异二聚体α1β1、α2β1、α3β1、α5β1、αvβ3和αvβ5在NHBCs的细胞表面组成性表达。NHBCs不表达整合素α4β1和α6β1。随后的结合研究表明,NHBCs对胶原蛋白和层粘连蛋白的黏附由多种整合素介导,在存在针对α1β1、α2β1、α3β1和β1的功能阻断单克隆抗体(Mabs)组合时,细胞附着几乎完全受到抑制。相比之下,在存在针对α3β1、α5β1和β1的阻断Mabs时,NHBCs对纤连蛋白的黏附仅部分受到抑制(50%)。在存在针对αvβ3的功能阻断Mab时,还发现NHBCs对胶原蛋白、层粘连蛋白、纤连蛋白和玻连蛋白的附着未受影响。本研究结果表明,β1整合素似乎是人类成骨样细胞用于黏附胶原蛋白、层粘连蛋白及部分纤连蛋白的主要黏附受体亚家族。